Incidence of New-Onset Seizures in Mild to Moderate Alzheimer DiseaseIRIZARRY, Michael C; SHELIA JIN; ISHIHARA, Lianna S et al.Archives of neurology (Chicago). 2012, Vol 69, Num 3, pp 368-372, issn 0003-9942, 5 p.Article

Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized TrialQUINN, Joseph F; RAMAN, Rema; SHINTO, Lynne et al.JAMA, the journal of the American Medical Association. 2010, Vol 304, Num 17, pp 1903-1911, issn 0098-7484, 9 p.Article

Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkersKRAJEWSKA, Maryla; KIM, Hoguen; SUZUKI, Koichi et al.Clinical cancer research. 2005, Vol 11, Num 15, pp 5451-5461, issn 1078-0432, 11 p.Article

ADCS prevention instrument project: pharmacoeconomics : Assessing health-related resource use among healthy elderlySANO, Mary; ZHU, Carolyn W; WHITEHOUSE, Peter J et al.Alzheimer disease and associated disorders. 2006, Vol 20, Num 4, issn 0893-0341, S191-S202, SUP3Article

Frequency of behavioral symptoms characterizes agitation in Alzheimer's diseaseTRACTENBERG, Rochelle E; GAMST, Anthony; WEINER, Myron F et al.International journal of geriatric psychiatry. 2001, Vol 16, Num 9, pp 886-891, issn 0885-6230Article

Prevalence of symptoms on the CERAD behavior rating scale for Dementia in normal elderly subjects and Alzheimer's disease patientsTRACTENBERG, Rochelle E; PATTERSON, Marian; WEINER, Myron F et al.The Journal of neuropsychiatry and clinical neurosciences. 2000, Vol 12, Num 4, pp 472-479, issn 0895-0172Article

Antioxidants for Alzheimer Disease: A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker MeasuresGALASKO, Douglas R; PESKIND, Elaine; AISEN, Paul et al.Archives of neurology (Chicago). 2012, Vol 69, Num 7, pp 836-841, issn 0003-9942, 6 p.Article

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease : sa randomised, double-blind, placebo-controlled study. CommentaryBURNS, Alistair; JACOBY, Robin; DOODY, Rachelle S et al.Lancet (British edition). 2008, Vol 372, Num 9634, issn 0140-6736, 179-180, 207-215 [11 p.]Article

Vitamin E and donepezil for the treatment of mild cognitive impairmentPETERSEN, Ronald C; THOMAS, Ronald G; PFEIFFER, Eric et al.The New England journal of medicine. 2005, Vol 352, Num 23, pp 2379-2388, issn 0028-4793, 10 p.Article

Estrogen levels do not correlate with improvement in cognitionTHAL, Leon J; THOMAS, Ronald G; MULNARD, Ruth et al.Archives of neurology (Chicago). 2003, Vol 60, Num 2, pp 209-212, issn 0003-9942, 4 p.Article

Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin : A placebo-controlled studyRASKIND, Murray A; PESKIND, Elaine R; THOMAS, Ronald G et al.The American journal of psychiatry. 2003, Vol 160, Num 2, pp 371-373, issn 0002-953X, 3 p.Article

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's DiseaseDOODY, Rachelle S; THOMAS, Ronald G; SIEMERS, Eric et al.The New England journal of medicine. 2014, Vol 370, Num 4, pp 311-321, issn 0028-4793, 11 p.Article

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's DiseaseDOODY, Rachelle S; RAMAN, Rema; AISEN, Paul S et al.The New England journal of medicine. 2013, Vol 369, Num 4, pp 341-350, issn 0028-4793, 10 p.Article

Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer DiseaseTARIOT, Pierre N; SCHNEIDER, Lon S; PORSTEINSSON, Anton et al.Archives of general psychiatry. 2011, Vol 68, Num 8, pp 853-861, issn 0003-990X, 9 p.Article

MRI Substudy Participation in Alzheimer Disease (AD) Clinical Trials: Baseline Comparability of a Substudy Sample to Entire Study PopulationRAMAN, Rema; THOMAS, Ronald G; WEINER, Michael W et al.Alzheimer disease and associated disorders. 2009, Vol 23, Num 4, pp 333-336, issn 0893-0341, 4 p.Article

Self-management of age-related macular degeneration at the 6-month follow-up: A randomized controlled trialBRODY, Barbara L; ROCH-LEVECQ, Anne-Catherine; THOMAS, Ronald G et al.Archives of ophthalmology (1960). 2005, Vol 123, Num 1, pp 46-53, issn 0003-9950, 8 p.Article

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: A randomized controlled trialAISEN, Paul S; SCHAFER, Kimberly A; GRUNDMAN, Michael et al.JAMA, the journal of the American Medical Association. 2003, Vol 289, Num 21, pp 2819-2826, issn 0098-7484, 8 p.Article

Metabolic syndrome and ischemic heart disease in elderly men and womenLINDBLAD, Ulf; LANGER, Robert D; WINGARD, Deborah L et al.American journal of epidemiology. 2001, Vol 153, Num 5, pp 481-489, issn 0002-9262Article